Clinical Trials Logo

Hyponatremia clinical trials

View clinical trials related to Hyponatremia.

Filter by:

NCT ID: NCT02432157 Recruiting - Clinical trials for Subarachnoid Hemorrhage

Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:

HS3
Start date: January 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Subarachnoid hemorrhage (SAH) occurs after rupture of cerebral aneurysms. Treatment of SAH focuses on avoiding medical complications including cerebral vasospasm, which may result in limited circulation to the brain. Cerebral vasospasm, or thinning of the arteries of the brain, is a feared complication that could potentially cause stroke and worst outcomes after SAH. Hypertonic saline (HTS) is a compound that may be used to prevent vasospasm following SAH by enhancing the circulation in the brain. This study will evaluate if a protocol of volume expansion with HTS is safe and effective in patients with subarachnoid hemorrhage for the prevention of cerebral vasospasm.

NCT ID: NCT01748331 Recruiting - Heart Failure Clinical Trials

The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia

Decongest
Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of fluid restriction and the neurohormonal mechanisms in the development of hyponatremia in patients with congestive heart failure and hyponatremia. The hypothesis is that strict fluid restriction leads to a larger increase in plasma sodium than standard treatment in patients with decompensated heart failure associated with hyponatremia. A secondary hypothesis is that the neurohormonal change is greater in patients treated with strict fluid restriction versus standard treatment.

NCT ID: NCT01507727 Recruiting - Clinical trials for Non-hypovolemic Non-acute Hyponatremia

Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

Start date: January 2012
Phase: Phase 2/Phase 3
Study type: Interventional

This drug has been developed to treat Hyponatremia. The primary purpose of this study is to verify the efficacy and safety of seven-day repeated oral administration of tolvaptan at 15, 30, and 60 mg or placebo in patients with Non-hypovolemic Non-acute Hyponatremia secondary to Congestive Heart Failure (CHF), hepatic cirrhosis or Syndrome of Inappropriate Antidiuretic Hormone (SIADH), despite receiving standard therapy. This study is being conducted in China.

NCT ID: NCT01219270 Recruiting - Clinical trials for Percutaneous Coronary Intervention

Radiocontrast Media Induced Hyponatremia

Start date: October 2010
Phase: N/A
Study type: Observational

Osmolality of contrast media can be resulted in translocational hyponatremia after percutaneous coronary intervention.

NCT ID: NCT00636857 Recruiting - Hyponatremia Clinical Trials

Postoperative Hyponatremia - Are There Gender Differences?

Start date: March 2008
Phase: N/A
Study type: Interventional

The proposed study will focus on anesthesia and anesthesia-induced hypotension as a possible cause for postoperative fluid retention and hyponatremia, and investigate gender differences in this response.